Mechanistically, RKIP acts primarily as tumour suppressor also in melanoma, in fact, its silencing results in increased expression of various oncogenes (KIT, BCL3, MAF, MYC, MYCL, HOXA9, CDC25B, and PIM1), most of which are associated with the transcription factor NANOG. The gene discussed is PEBP1; the disease is melanoma.